NO20002529D0 - Substituerte 2-(2,6-diokso-3-fluorpiperidin-3-yl)- isoindoliner og deres anvendelse for Õ redusere tnf<alfa> nivÕer - Google Patents

Substituerte 2-(2,6-diokso-3-fluorpiperidin-3-yl)- isoindoliner og deres anvendelse for Õ redusere tnf<alfa> nivÕer

Info

Publication number
NO20002529D0
NO20002529D0 NO20002529A NO20002529A NO20002529D0 NO 20002529 D0 NO20002529 D0 NO 20002529D0 NO 20002529 A NO20002529 A NO 20002529A NO 20002529 A NO20002529 A NO 20002529A NO 20002529 D0 NO20002529 D0 NO 20002529D0
Authority
NO
Norway
Prior art keywords
dioxo
fluoropiperidin
isoindolines
levels
alfa
Prior art date
Application number
NO20002529A
Other languages
English (en)
Other versions
NO318737B1 (no
NO20002529L (no
Inventor
George W Muller
Hon-Wah Man
David I Stirling
Roger Shen-Chu Chen
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of NO20002529D0 publication Critical patent/NO20002529D0/no
Publication of NO20002529L publication Critical patent/NO20002529L/no
Publication of NO318737B1 publication Critical patent/NO318737B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002529A 1997-11-18 2000-05-16 Substituerte 2-(2,6-diokso-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse for a redusere TNFa-nivaer NO318737B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
PCT/US1998/024453 WO1999046258A1 (en) 1998-03-13 1998-11-17 SUBSTITUTED 2-(2,6-DIOXO-3-FLUOROPIPERIDIN-3-YL)-ISOINDOLINES AND THEIR USE TO REDUCE TNFα LEVELS

Publications (3)

Publication Number Publication Date
NO20002529D0 true NO20002529D0 (no) 2000-05-16
NO20002529L NO20002529L (no) 2000-06-30
NO318737B1 NO318737B1 (no) 2005-05-02

Family

ID=26719049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002529A NO318737B1 (no) 1997-11-18 2000-05-16 Substituerte 2-(2,6-diokso-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse for a redusere TNFa-nivaer

Country Status (14)

Country Link
EP (3) EP1062214B1 (no)
AT (2) ATE233753T1 (no)
AU (1) AU752958B2 (no)
CY (1) CY1106100T1 (no)
CZ (1) CZ299808B6 (no)
DE (2) DE69834668T2 (no)
DK (1) DK1308444T3 (no)
ES (2) ES2192342T3 (no)
FI (1) FI20001192A (no)
HK (1) HK1054381B (no)
NO (1) NO318737B1 (no)
PT (1) PT1308444E (no)
SI (1) SI1308444T1 (no)
SK (1) SK7382000A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299253B6 (cs) * 1998-03-16 2008-05-28 Celgene Corporation Isoindolinový derivát, jeho použití pro výrobu léciva a farmaceutická kompozice tento derivát obsahující
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
ES2339425T3 (es) * 1996-07-24 2010-05-20 Celgene Corporation 2-(2,6-dioxopiperidin-3-il)-ftalimidas y -1-oxoisoindolinas sustituidas y procedimiento para reducir los niveles de tnf-alfa.
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines

Also Published As

Publication number Publication date
EP1062214A1 (en) 2000-12-27
EP1308444A1 (en) 2003-05-07
DE69811962T2 (de) 2003-08-28
CY1106100T1 (el) 2011-06-08
CZ299808B6 (cs) 2008-12-03
CZ20001822A3 (cs) 2000-11-15
AU1413899A (en) 1999-09-27
ATE327228T1 (de) 2006-06-15
PT1308444E (pt) 2006-08-31
SK7382000A3 (en) 2000-12-11
NO318737B1 (no) 2005-05-02
HK1054381A1 (en) 2003-11-28
AU752958B2 (en) 2002-10-03
ES2262753T3 (es) 2006-12-01
DK1308444T3 (da) 2006-09-18
EP1710242A1 (en) 2006-10-11
ES2192342T3 (es) 2003-10-01
SI1308444T1 (sl) 2007-04-30
FI20001192A (fi) 2000-07-14
EP1308444B1 (en) 2006-05-24
DE69811962D1 (de) 2003-04-10
DE69834668D1 (de) 2006-06-29
DE69834668T2 (de) 2007-01-11
HK1054381B (zh) 2006-10-13
ATE233753T1 (de) 2003-03-15
EP1062214B1 (en) 2003-03-05
NO20002529L (no) 2000-06-30

Similar Documents

Publication Publication Date Title
TR200002627T2 (tr) İkameli 2-(2,6- (Diokso-3-floropiperidin-3-İI) -izoindolinler ve TNF alfa seviyelerini düşürmek için kullanılmaları
TR200000107T2 (tr) Sübstitüe edilmiş 2-(2,6-dioksopiperidin-3-il) -ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
DK2305248T3 (da) Substituerede phenethylsulfoner og fremgangsmåde til reduktion af tnf-alfa-niveauer
NO996529L (no) Substituerte alkanohydrokxaminsyrer og fremgangsmåte for å redusere TNF-&lt;alfa&gt;-nivåer
DE69417576D1 (de) Zementzusatzmittel
DE69128627T2 (de) Tnf-inhibitoren
DE3889533T2 (de) Giesspunkterniedrigende methacrylatadditive und -zusammensetzungen.
DE69210797D1 (de) Prolyl Endopeptidase Inhibitor
NO20002529L (no) Substituerte 2-(2,6-diokso-3-fluorpiperidin-3-yl)- isoindoliner og deres anvendelse for Õ redusere tnf&lt;alfa&gt; nivÕer
EA200200189A1 (ru) Применение ингибиторов интерлейкина 18
KR930006833U (ko) 벽돌
DE9218155U1 (de) Mauerstein-Bausatz
IT217447Z2 (it) Mobile articolato per ufficio o studio con piano ausiliario e cassettiera estraibili simultaneamente
BR9100508A (pt) Salva-vidas hidraulico
BR9102799A (pt) Salva-vidas hidraulico
MX9100939A (es) Bloques de diferentes medidas de cemento y jaltete.
NO920441D0 (no) Tnf-inhibitorer
KR930008951U (ko) 개량 벽돌
BR7102837U (pt) Tijolo belavistao
DE29803640U1 (de) Umkleidung von Möbel-Bausteinen
ATE105581T1 (de) Giesspunkterniedrigende methacrylatadditive und - zusammensetzungen.
ITBS910012A0 (it) Griglia per caditoia
KR950008034U (ko) 산소배출기능을 가진 냄비

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees